HERON THERAPEUTICS, INC. /DE/ Annual Selling and Marketing Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Selling and Marketing Expense history and growth rate from 2014 to 2023.
  • Heron Therapeutics, Inc. /De/ Selling and Marketing Expense for the quarter ending June 30, 2024 was $13.6M, a 35.8% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Selling and Marketing Expense for the twelve months ending June 30, 2024 was $50.3M, a 35.9% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2023 was $67.6M, a 18% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2022 was $82.5M, a 5.35% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2021 was $87.2M, a 36.5% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $67.6M -$14.9M -18% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $82.5M -$4.67M -5.35% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $87.2M +$23.3M +36.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $63.9M -$25.9M -28.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $89.8M +$25.2M +38.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $64.6M +$8M +14.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $56.6M +$8.93M +18.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $47.7M +$30.3M +175% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 $17.3M +$8.64M +99.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $8.71M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.